The year 2014 proved to be a year of successes for pharmaceutical companies. With the drug makers' hard work on new medicines rewarded with FDA approvals, patients with rare and serious diseases also benefit.
The year 2014 proved to be a year of successes for pharmaceutical companies. With the drug makers' hard work on new medicines rewarded with FDA approvals, patients with rare and serious diseases also benefit.